Neurocrine Bioscience buy tamam
Start price
25.08.15
/
50%
€40.64
Target price
21.09.15
€49.99
Performance (%)
23.60%
End price
21.09.15
€50.22
Summary
This prediction ended on 21.09.15 with a price of €50.22. The prediction had a final performance of 23.60%. tamam has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Neurocrine Bioscience | 2.873% | 2.873% | 46.328% | 68.428% |
iShares Core DAX® | -0.922% | -1.993% | 13.399% | 16.075% |
iShares Nasdaq 100 | 0.371% | -0.868% | 41.541% | 46.938% |
iShares Nikkei 225® | 2.224% | -5.187% | 20.497% | 4.643% |
iShares S&P 500 | -0.026% | -0.918% | 30.410% | 42.418% |
Comments by tamam for this prediction
In the thread Neurocrine Bioscience diskutieren
tamam stimmt der Outperform-Einschätzung der institutionellen Analysten zu
tamam stimmt am 25.08.2015 der Outperform-Einschätzung der institutionellen Analysten mit dem Kursziel 55.42€ zu.
With Phase 3 data in tardive dyskinesia and Phase 1/2 data in Tourette syndrome with NBI-98854, Phase 3 data in endometriosis and Phase 2b data in uterine fibroids with elagolix, and Phase 1/2 data with NBI-77860 in congenital adrenal hyperplasia.
(Vom Mitglied beendet)
Stopped prediction by tamam for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€77.15
23.02.18
23.02.18
€112.75
04.11.21
04.11.21
6.34%
05.11.21
05.11.21